Tychan Pte Ltd.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans (NCT04649515) | Tychan Pte Ltd. | 2020-12-04 |
| Safety of TY027, a Treatment for COVID-19, in Humans (NCT04429529) | Tychan Pte Ltd. | 2020-06-09 |
| Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients (NCT03776695) | Tychan Pte Ltd. | 2018-10-09 |
| Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans (NCT03443830) | Tychan Pte Ltd. | 2018-02-08 |
Track Tychan Pte Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.